Integra Lifesciences Holdings Corp (STU:IL3)
€ 16.4 +0.40 (+2.5%) Market Cap: 1.28 Bil Enterprise Value: 2.84 Bil PE Ratio: 0 PB Ratio: 1.40 GF Score: 74/100

Q1 2026 Integra Lifesciences Holdings Corp Earnings Call Transcript

May 05, 2026 / 12:30PM GMT
Release Date Price: €9.6 (+5.49%)
Operator

Good day. Welcome to Integra LifeSciences first quarter 2026 financial results. (Operator Instructions) . Also, note this call is being recorded.

I would now like to turn the call over to Chris Ward, Senior Director of Investor Relations. Please go ahead.

Chris Ward
Integra Lifesciences Holdings Corp - IR Contact Officer

Good morning, and thank you for joining the Integra LifeSciences first quarter 2026 earnings conference call. Joining me on the call are Stuart Essig, Chairman, President, and Chief Executive Officer, and Lea Knight, Chief Financial Officer.

This morning we issued two press releases. The first announcing the CEO transition and other organizational changes, and the second announcing our first quarter 2026 financial results. The releases and earnings presentation that we will reference during the call are available at integralife.com under Investors, Events and Presentations in a file named First Quarter 2026 Earnings Call Presentation.

Before we begin, I want to remind you that many statements made during this call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot